74 related articles for article (PubMed ID: 2731780)
21. Intraperitoneal fibrin-formation and its inhibition in CAPD.
Gries E; Paar D; Graben N; Bock KD
Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
[TBL] [Abstract][Full Text] [Related]
22. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrinopeptide A and beta-thromboglobulin in patients with chest pain.
Douglas JT; Lowe GD; Forbes CD; Prentice CR
Thromb Haemost; 1983 Aug; 50(2):541-2. PubMed ID: 6195751
[TBL] [Abstract][Full Text] [Related]
24. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
Cronlund M; Hardin J; Burton J; Lee L; Haber E; Bloch KJ
J Clin Invest; 1976 Jul; 58(1):142-51. PubMed ID: 932202
[TBL] [Abstract][Full Text] [Related]
25. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
26. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
27. Increased thrombin generation in normal pregnancy.
Pinto S; Abbate R; Rostagno C; Bruni V; Rosati D; Neri Serneri GG
Acta Eur Fertil; 1988; 19(5):263-7. PubMed ID: 3252655
[TBL] [Abstract][Full Text] [Related]
28. Thrombin generation in acute myeloblastic leukemia.
Scharf RE; Stoffels U; Schneider W
Haematol Blood Transfus; 1990; 33():357-61. PubMed ID: 2323642
[No Abstract] [Full Text] [Related]
29. [Fibrinopeptide A and protein C in heart patients with acute coronary syndromes].
Denchev S; Kamenov V; Ivanova R; Tomov I
Vutr Boles; 1988; 27(6):80-3. PubMed ID: 3247711
[TBL] [Abstract][Full Text] [Related]
30. [A method for the assay of fibrinopeptide in plasma].
Piana A; Armani U; Saccarello A; Boeri D; Maiello M; Falzetti G
Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1558-61. PubMed ID: 6661319
[TBL] [Abstract][Full Text] [Related]
31. Analysis of human fibrinopeptides by high-performance liquid chromatography.
Kehl M; Lottspeich F; Henschen A
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
[TBL] [Abstract][Full Text] [Related]
32. Hereditary dysfibrinogenemia characterized by slow fibrinopeptide release and competitive inhibition of thrombin.
Laugen RH; Bithell TC
Acta Haematol; 1984; 71(3):150-7. PubMed ID: 6424379
[TBL] [Abstract][Full Text] [Related]
33. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
Murakoshi T
Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
[TBL] [Abstract][Full Text] [Related]
34. [Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings)].
Hofmann V; Ermanni M; Straub PW
Schweiz Med Wochenschr; 1978 Oct; 108(41):1600. PubMed ID: 694497
[TBL] [Abstract][Full Text] [Related]
35. Impurity of thrombin preparations for clinical use.
Ueshima S; Yamamoto T; Okada K; Sakai T; Matsuo O
J Clin Hosp Pharm; 1985 Jun; 10(2):193-202. PubMed ID: 4019792
[TBL] [Abstract][Full Text] [Related]
36. Guide wire thrombogenicity measured by fibrinopeptide A radioimmunoassay.
Casarella WJ; Wilner GD
AJR Am J Roentgenol; 1977 Mar; 128(3):363-6. PubMed ID: 402829
[TBL] [Abstract][Full Text] [Related]
37. Thrombin activity and oral anticoagulant therapy: a preliminary study.
Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Sanna MP; Farci P; Balestrieri A
Haemostasis; 1989; 19(3):142-6. PubMed ID: 2744630
[TBL] [Abstract][Full Text] [Related]
38. Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
Mariani G; Iacopino G; Pasquali-Lasagni R
Int J Clin Lab Res; 1992; 22(2):111-4. PubMed ID: 1504303
[TBL] [Abstract][Full Text] [Related]
39. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
40. Elevated fibrinopeptide A levels in patients with clinically localised breast carcinoma.
Auger MJ; Galloway MJ; Leinster SJ; McVerry BA; Mackie MJ
Haemostasis; 1987; 17(6):336-9. PubMed ID: 3428719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
